-
1
-
-
0034255796
-
IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety
-
Aug
-
Albertini R.J., Anderson D., Douglas G.R., Hagmar L., Hemminki K., Merlo F., et al. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutation Research 463 2 (2000) 111-172 Aug
-
(2000)
Mutation Research
, vol.463
, Issue.2
, pp. 111-172
-
-
Albertini, R.J.1
Anderson, D.2
Douglas, G.R.3
Hagmar, L.4
Hemminki, K.5
Merlo, F.6
-
4
-
-
0036427515
-
Separation of human lymphocytes from citrated blood by density gradient (NycoPrep) centrifugation: Monocyte depletion depending upon activation of membrane potassium channels
-
Boyum A., Brincker Fjerdingstad H., Martinsen I., Lea T., and Lovhaug D. Separation of human lymphocytes from citrated blood by density gradient (NycoPrep) centrifugation: Monocyte depletion depending upon activation of membrane potassium channels. Scandinavian Journal of Immunology 1 (2002) 76-84
-
(2002)
Scandinavian Journal of Immunology
, vol.1
, pp. 76-84
-
-
Boyum, A.1
Brincker Fjerdingstad, H.2
Martinsen, I.3
Lea, T.4
Lovhaug, D.5
-
6
-
-
33845978493
-
Mechanisms of drug resistance
-
Souhami R.L., Tannock I., Hohenberger P., and Horiot J.-C. (Eds), Oxford University Press, Oxford
-
de Jong S., Mulder N.H., and de Vries E.G.E. Mechanisms of drug resistance. In: Souhami R.L., Tannock I., Hohenberger P., and Horiot J.-C. (Eds). Oxford Textbook of Oncology (2002), Oxford University Press, Oxford 755-771
-
(2002)
Oxford Textbook of Oncology
, pp. 755-771
-
-
de Jong, S.1
Mulder, N.H.2
de Vries, E.G.E.3
-
7
-
-
0030998763
-
Role of oncogenes in resistance and killing by cancer therapeutic agents
-
el-Deiry W.S. Role of oncogenes in resistance and killing by cancer therapeutic agents. Current Opinion in Oncology 9 (1997) 79-87
-
(1997)
Current Opinion in Oncology
, vol.9
, pp. 79-87
-
-
el-Deiry, W.S.1
-
8
-
-
0025122529
-
CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphoma
-
Fisher R.I. CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphoma. Important Advances in Oncology (1990) 217-225
-
(1990)
Important Advances in Oncology
, pp. 217-225
-
-
Fisher, R.I.1
-
9
-
-
0027394689
-
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
-
Fisher R.I., Gaynor E.R., Dahlberg S., Oken M.M., Grogan T.M., Mize E.M., et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New England Journal of Medicine 328 (1993) 1002-1006
-
(1993)
New England Journal of Medicine
, vol.328
, pp. 1002-1006
-
-
Fisher, R.I.1
Gaynor, E.R.2
Dahlberg, S.3
Oken, M.M.4
Grogan, T.M.5
Mize, E.M.6
-
11
-
-
0005179167
-
Resistance to multiple chemotherapeutic agents in human cancer cells
-
Gottesman M.M., and Pastan I. Resistance to multiple chemotherapeutic agents in human cancer cells. Trends in Pharmacological Sciences 9 (1988) 54-58
-
(1988)
Trends in Pharmacological Sciences
, vol.9
, pp. 54-58
-
-
Gottesman, M.M.1
Pastan, I.2
-
13
-
-
0020644818
-
6-Methylguanine-DNA methyltransferase of human lymphoid cells: Structural and kinetic properties and absence in repair-deficient cells
-
6-Methylguanine-DNA methyltransferase of human lymphoid cells: Structural and kinetic properties and absence in repair-deficient cells. Cancer Research 43 (1983) 3247-3252
-
(1983)
Cancer Research
, vol.43
, pp. 3247-3252
-
-
Harris, A.L.1
Karran, P.2
Lindahl, T.3
-
14
-
-
0028988762
-
DNA-damaging effect of cyclophosphamide on human blood cells in vivo and in vitro studied with the single-cell gel test (comet assay)
-
Hartmann A., Herkommer K., Gluck M., and Speit G. DNA-damaging effect of cyclophosphamide on human blood cells in vivo and in vitro studied with the single-cell gel test (comet assay). Environmental and Molecular Mutagenesis 25 (1995) 180-187
-
(1995)
Environmental and Molecular Mutagenesis
, vol.25
, pp. 180-187
-
-
Hartmann, A.1
Herkommer, K.2
Gluck, M.3
Speit, G.4
-
16
-
-
0022263928
-
The cytotoxic and mutagenic effects of alkylating agents on human lymphoid cells are caused by different DNA lesions
-
Karran P., and Williams S.A. The cytotoxic and mutagenic effects of alkylating agents on human lymphoid cells are caused by different DNA lesions. Carcinogenesis 6 (1985) 789-792
-
(1985)
Carcinogenesis
, vol.6
, pp. 789-792
-
-
Karran, P.1
Williams, S.A.2
-
17
-
-
0034213140
-
Single cell gel electrophoresis assay: A new technique for human biomonitoring studies
-
Kassie F., Parzefall W., and Knasmuller S. Single cell gel electrophoresis assay: A new technique for human biomonitoring studies. Mutation Research 463 (2000) 13-31
-
(2000)
Mutation Research
, vol.463
, pp. 13-31
-
-
Kassie, F.1
Parzefall, W.2
Knasmuller, S.3
-
19
-
-
0000994348
-
DNA as a target in cancer chemotherapy: Measurement of macromolecular DNA damage produced in mammalian cells by anticancer agents and carcinogens
-
Kohn K.W. DNA as a target in cancer chemotherapy: Measurement of macromolecular DNA damage produced in mammalian cells by anticancer agents and carcinogens. Methods in Cancer Research 16 (1979) 291-345
-
(1979)
Methods in Cancer Research
, vol.16
, pp. 291-345
-
-
Kohn, K.W.1
-
20
-
-
0029929867
-
Clinical multidrug resistance in cancer: A multifactorial problem
-
Lehnert M. Clinical multidrug resistance in cancer: A multifactorial problem. European Journal of Cancer 32A (1996) 912-920
-
(1996)
European Journal of Cancer
, vol.32 A
, pp. 912-920
-
-
Lehnert, M.1
-
21
-
-
32544458945
-
Predicting the transactivation activity of p53 missense mutants using a four-body potential score derived from Delaunay tessellations
-
Mathe E., Olivier M., Kato S., Ishioka C., Vaisman I., and Hainaut P. Predicting the transactivation activity of p53 missense mutants using a four-body potential score derived from Delaunay tessellations. Human Mutation 2 (2006) 163-172
-
(2006)
Human Mutation
, vol.2
, pp. 163-172
-
-
Mathe, E.1
Olivier, M.2
Kato, S.3
Ishioka, C.4
Vaisman, I.5
Hainaut, P.6
-
22
-
-
17144460571
-
Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma
-
Moller M.B., Nielsen O., and Pedersen N.T. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma. Histopathology 41 (2002) 322-330
-
(2002)
Histopathology
, vol.41
, pp. 322-330
-
-
Moller, M.B.1
Nielsen, O.2
Pedersen, N.T.3
-
23
-
-
1842335776
-
DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia
-
Muller M.R., Buschfort C., Thomale J., Lensing C., M. F. R., and Seeber S. DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia. Clinical Cancer Research 3 (1997) 2055-2061
-
(1997)
Clinical Cancer Research
, vol.3
, pp. 2055-2061
-
-
Muller, M.R.1
Buschfort, C.2
Thomale, J.3
Lensing, C.4
M. F., R.5
Seeber, S.6
-
24
-
-
0031860937
-
Expression of p53 predicts treatment failure in aggressive non-Hodgkin's lymphomas
-
Navaratnam S., Williams G.J., Rubinger M., Pettigrew N.M., Mowat M.R., Begleiter A., et al. Expression of p53 predicts treatment failure in aggressive non-Hodgkin's lymphomas. Leukemia and Lymphoma 29 (1998) 139-144
-
(1998)
Leukemia and Lymphoma
, vol.29
, pp. 139-144
-
-
Navaratnam, S.1
Williams, G.J.2
Rubinger, M.3
Pettigrew, N.M.4
Mowat, M.R.5
Begleiter, A.6
-
26
-
-
0030012151
-
Detection of DNA-crosslinking agents with the alkaline comet assay
-
Pfuhler S., and Wolf H.U. Detection of DNA-crosslinking agents with the alkaline comet assay. Environmental and Molecular Mutagenesis 27 (1996) 196-201
-
(1996)
Environmental and Molecular Mutagenesis
, vol.27
, pp. 196-201
-
-
Pfuhler, S.1
Wolf, H.U.2
-
27
-
-
0026566088
-
Systemic genotoxic effects of tobacco-related nitrosamines following oral and inhalational administration to Sprague-Dawley rats
-
Pool-Zobel B.L., Klein R.G., Liegibel U.M., Kuchenmeister F., Weber S., and Schmezer P. Systemic genotoxic effects of tobacco-related nitrosamines following oral and inhalational administration to Sprague-Dawley rats. Clinical Investigator 70 (1992) 299-306
-
(1992)
Clinical Investigator
, vol.70
, pp. 299-306
-
-
Pool-Zobel, B.L.1
Klein, R.G.2
Liegibel, U.M.3
Kuchenmeister, F.4
Weber, S.5
Schmezer, P.6
-
28
-
-
0031464448
-
Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies
-
Reed J.C. Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies. Seminars in Hematology 34 (1997) 9-19
-
(1997)
Seminars in Hematology
, vol.34
, pp. 9-19
-
-
Reed, J.C.1
-
30
-
-
0023919963
-
A simple technique for quantitation of low levels of DNA damage in individual cells
-
Singh N.P., McCoy M.T., Tice R.R., and Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research 175 (1988) 184-191
-
(1988)
Experimental Cell Research
, vol.175
, pp. 184-191
-
-
Singh, N.P.1
McCoy, M.T.2
Tice, R.R.3
Schneider, E.L.4
-
31
-
-
0025962780
-
Non-random cell killing in cryopreservation: Implications for performance of the battery of leukocyte tests (BLT), I. Toxic and immunotoxic effects
-
Strauss G.H. Non-random cell killing in cryopreservation: Implications for performance of the battery of leukocyte tests (BLT), I. Toxic and immunotoxic effects. Mutation Research 252 (1991) 1-15
-
(1991)
Mutation Research
, vol.252
, pp. 1-15
-
-
Strauss, G.H.1
-
33
-
-
0034037611
-
Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing
-
Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., et al. Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing. Environmental and Molecular Mutagenesis 35 (2000) 206-221
-
(2000)
Environmental and Molecular Mutagenesis
, vol.35
, pp. 206-221
-
-
Tice, R.R.1
Agurell, E.2
Anderson, D.3
Burlinson, B.4
Hartmann, A.5
Kobayashi, H.6
-
34
-
-
0025761928
-
Prognostic factors in aggressive lymphoma
-
Velasquez W.S. Prognostic factors in aggressive lymphoma. Journal of Clinical Oncology 9 (1991) 1320-1321
-
(1991)
Journal of Clinical Oncology
, vol.9
, pp. 1320-1321
-
-
Velasquez, W.S.1
-
35
-
-
0027487419
-
Prognostic factors in intermediate high grade lymphoma
-
Velasquez W.S. Prognostic factors in intermediate high grade lymphoma. Cancer Treatment and Research 66 (1993) 37-52
-
(1993)
Cancer Treatment and Research
, vol.66
, pp. 37-52
-
-
Velasquez, W.S.1
-
36
-
-
0027517425
-
The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations
-
Villuendas R., Piris M.A., Algara P., Sanchez-Beato M., Sanchez-Verde L., Martinez J.C., et al. The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations. Blood 82 (1993)
-
(1993)
Blood
, vol.82
-
-
Villuendas, R.1
Piris, M.A.2
Algara, P.3
Sanchez-Beato, M.4
Sanchez-Verde, L.5
Martinez, J.C.6
-
38
-
-
0031018994
-
Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas
-
Wilson W.H., Teruya-Feldstein J., Fest T., Harris C., Steinberg S.M., Jaffe E.S., et al. Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas. Blood 89 (1997) 601-609
-
(1997)
Blood
, vol.89
, pp. 601-609
-
-
Wilson, W.H.1
Teruya-Feldstein, J.2
Fest, T.3
Harris, C.4
Steinberg, S.M.5
Jaffe, E.S.6
|